Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)

DSE:BXPHARMA Revenue

In the fiscal year ending June 30, 2026, Beximco Pharmaceuticals PLC. had annual revenue of 56.27B BDT with 14.55% growth. Beximco Pharmaceuticals PLC. had revenue of 14.84B in the quarter ending June 30, 2026, with 18.72% growth. That makes Beximco Pharmaceuticals PLC. the 11,911th largest company in the world by revenue and 13th in Bangladesh.

• Revenue: 56.27B
• Revenue Growth: +14.55%
• P/S Ratio: 1.14
• Revenue / Employee: 46.01M
• Employees: 1,223
• Market Cap: 64.02B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Bangladesh 44.90B 91.4%
• Export 4.07B 8.3%
• Unallocated 147.73M 0.3%

Fiscal year ended Jun 30, 2025 See the full DSE:BXPHARMA breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	56.27B	7.15B	14.55%
Jun 30, 2025	49.12B	4.73B	10.65%
Jun 30, 2024	44.39B	5.12B	13.05%
Jun 30, 2023	39.27B	4.60B	13.26%
Jun 30, 2022	34.67B	5.18B	17.55%

Data Source: S&P Global Market Intelligence Last updated: Nov 9, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error